References: |
1. Beverley, P.C.L. and Callard, R.E. (1981) Eur. J. Immunol. 11: 329-334. 2. Zarkesh-Esfahani, H. et al. (2001) J. Immunol. 167: 4593 - 4599. 3. Kung, P. et al. (1979) Science. 206: 347-9. 4. Clevers, H. et al. (1988) Eur. J. Immunol. 18: 705-10. 5. Clark, E.A. et al. (1983) Immunogenetics 18: 599-615. 6. Clevers, H. et al. (1988) Annu. Rev. Immunol. 6: 629-62. 7. Meuer, S.C. et al. (1983) Nature 303: 808-10. 8. Clark, E.A. et al. (1989) Immunology Today 10: 225-8. 9. Campana, D. et al. (1987) J. Immunol. 138: 648-55. 10. Erber, W.N. et al. (1984) Lancet 1(8385): 1042-6. 11. Erber, W.N. et al. (1986) Lancet 1(8485): 761-5. 12. Denning, S.M. et al. (1987) Activation of human thymocytes via CD3 and CD2 molecules. In McMichael, A.J. et al. Leucocyte Typing III: White Cell Differentiation Antigens. Edited by Oxford University Press pp 144-7. 13. Grogan, T.M. et al. (1985) P Am. J. Clin. Pathol. 83: 271-88. 14. Maggiorella, M. et al. (1998) Blood. 91 (9): 3103 - 3111. |